At FuseBio, we are dedicated to developing transformative immune modulating therapeutics for patients with cancers. Our therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that spare healthy tissues.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Los Angeles, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.fusebiotx.com
- Keywords
- drug discovery, immunoncology, immunology, cancer treatment, nk cell biology, t cell biology, antibodies, protein engineering.
- HQ
- Los Angeles, CA
Fuse Biotherapeutics Questions
Fuse Biotherapeutics's website is http://www.fusebiotx.com
Fuse Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/fusebiotx
Fuse Biotherapeutics has
5 employees.
View email and phone details for 5
employees at Fuse Biotherapeutics.
Fuse Biotherapeutics's industry is
Biotechnology Research
Fuse Biotherapeutics's top competitors are
Nkgen Biotech, Inc.,
Hawkeye Bio, Ltd.,
Sanguine Biosciences,
Fusebio,
Pepromene Bio,
Max Biopharma, Inc.,
Duet Biotherapeutics,
Immunitybio, Inc.,
Calyx,
Caribou Biosciences.
Fuse Biotherapeutics's categories are Biotechnology Research
Fuse Biotherapeutics's founding year is 2021
